Opening book details…
About this book
SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer by Lin Long & Xiao-Xiao Pang & Fei Lei & Jia-Sheng Zhang & Wei Wang & Lian-Di Liao & Xiu-E Xu & Jian-Zhong He & Jian-Yi Wu & Zhi-Yong Wu & Li-Dong Wang & De-Chen Lin & En-Min Li & Li-Yan Xu is a book available to read on EtoBox.
- Author
- Lin Long & Xiao-Xiao Pang & Fei Lei & Jia-Sheng Zhang & Wei Wang & Lian-Di Liao & Xiu-E Xu & Jian-Zhong He & Jian-Yi Wu & Zhi-Yong Wu & Li-Dong Wang & De-Chen Lin & En-Min Li & Li-Yan Xu
- Publisher
- Springer International Publishing
- Published
- 2018
- Language
- EN
More by Lin Long & Xiao-Xiao Pang & Fei Lei & Jia-Sheng Zhang & Wei Wang & Lian-Di Liao & Xiu-E Xu & Jian-Zhong He & Jian-Yi Wu & Zhi-Yong Wu & Li-Dong Wang & De-Chen Lin & En-Min Li & Li-Yan Xu
Similar books
- NF-κB/Rel Transcription Factor Family — Tom Huxford, Gourisankar Ghosh (auth.), Hsiou-Chi Liou Ph.D. (2006)
- The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival — Nora Diéguez-Martínez & Sergio Espinosa-Gil & Guillermo Yoldi & Elisabet Megías-Roda & Idoia Bolinaga-Ayala & Maria Viñas-Casas & Gokhan Gorgisen & Inés Domingo-Ortí & Héctor Pérez-Montoyo & Jose R. Bayascas & Eva Colas & Xavier Dolcet & Jose M. Lizcano (2022)
- A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection — Michelle C. Lim & Gunter Maubach & Anna M. Birkl-Toeglhofer & Johannes Haybaeck & Michael Vieth & Mchael Naumann (2022)
- A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells — Hongli Yin & Ozge Karayel & Ying-Yin Chao & Thomas Seeholzer & Isabel Hamp & Oliver Plettenburg & Torben Gehring & Christina Zielinski & Matthias Mann & Daniel Krappmann (2022)
- DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway — Shenglan Liu & Liangmei He & Junhong Wu & Xinqiang Wu & Lu Xie & Wei Dai & Lingxia Chen & Fuhua Xie & Zhiping Liu (2021)
- Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy — Nasim Ebrahimi & Al-Hasnawi Rasool Riyadh Abdulwahid & Atena Mansouri & Nasrin Karimi & Rashid Jafardoust Bostani & Sheida Beiranvand & Samaneh Adelian & Roya Khorram & Reza Vafadar & Michael R. Hamblin & Amir Reza Aref (2024)